category,datetime,headline,id,image,related,source,summary,url
company,1769548500,"BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $250 Million Repurchase to Date in FY26",138275456,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BDX,Yahoo,"The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.05 per common share, payable on March 31, 2026, to holders of record on March 10, 2026. The indicated annual dividend rate is $4.20 per share.",https://finnhub.io/api/news?id=5eba1cc2fc95ba59661a422f8c3cb6485d7115ba1edf7ec30c2ba275f5036194
company,1769532420,BDX Introduces BD Research Cloud 7.0 for Advanced Flow Cytometry,138274076,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BDX,Yahoo,"BD launches BD Research Cloud 7.0 with AI-powered Horizon Panel Maker, boosting automation, data intelligence and productivity in flow cytometry.",https://finnhub.io/api/news?id=4cd390c98458d5705c6e766e6ac24b3e4cf40f8d9278dfbaa2903a468975db5b
company,1769532004,BDX vs. SAUHY: Which Stock Is the Better Value Option?,138274132,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BDX,Yahoo,BDX vs. SAUHY: Which Stock Is the Better Value Option?,https://finnhub.io/api/news?id=c0ee50adfa3a75999f3fa97c3c49d31c5b070fd79c6e1a9fb465d746b60d66cd
company,1769524802,Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term,138272653,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BDX,Yahoo,"Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",https://finnhub.io/api/news?id=fa80e601155908fd2d9d625d939fd8fb6c1f6cf22960cebe18775fa61e73ebbd
company,1769524673,"Target upgraded, Stryker downgraded: Wall Street's top analyst calls",138271171,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BDX,Yahoo,"Target upgraded, Stryker downgraded: Wall Street's top analyst calls",https://finnhub.io/api/news?id=393d1319ad6bb1f0bb9845d7cd2c2624f305f7b58e8ba64063f7f8d38d6159ab
company,1769523960,BD to Announce Financial Results for its First Quarter of Fiscal 2026,138271172,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BDX,Yahoo,"BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Monday, February 9, 2026 to discuss the Company's financial results for its first quarter of fiscal year 2026, which ended on December 31, 2025, and to provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors, and a replay will be made availab",https://finnhub.io/api/news?id=9acf6854df2eba87140e9d01476e2b7f904add6740f811ce769b60ad91ad0cb1
company,1769523900,Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business,138271174,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BDX,Yahoo,"Waters Corporation (NYSE: WAT) (the ""Company"" or ""Waters"") today announced that, at the Company's Special Meeting of Shareholders (the ""Special Meeting"") held today, Waters shareholders overwhelmingly voted to approve the issuance of shares of Waters common stock to shareholders of Becton, Dickinson and Company (NYSE: BDX) (""BD"") in connection with the proposed combination of BD's Biosciences & Diagnostic Solutions business with Waters.",https://finnhub.io/api/news?id=9eb4e108807a4d4dca469d3434de469be4aded2420b0caede44d157671dd378a
company,1769523900,BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business,138271173,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BDX,Yahoo,"BD (Becton, Dickinson and Company) (NYSE: BDX) (""BD"" or the ""Company"") today announced that the Company's Board of Directors has set the close of business on February 5, 2026, as the record date for the previously announced spin-off of BD's Biosciences & Diagnostic Solutions business to BD's shareholders. Immediately following the spin-off, the spun-off entity will be combined with Waters Corporation (NYSE: WAT) (""Waters"") in a Reverse Morris Trust transaction. The combination is expected to be",https://finnhub.io/api/news?id=c323e61642a9d1b2f139c8e656b319ea6e49fd20ba923f344496ce106ad7e47d
